The invention concerns chromenone derivatives of Formula I
or a pharmaceutically-acceptable salts thereof, wherein each of R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, n and R
9
has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.